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Abstract
Objective: To determine the prevalence of metastasis to 
appendix from primary surgery of ovarian epithelial cancer 
at National General Hospital Dr. Cipto Mangunkusumo 
(RSCM), Indonesia.
Methods: A cross sectional study was done using ovarian 
epithelial cancer patient medical record whose primary 
ovarian cancer and appendectomy surgery were conducted 
on July to December 2019 at RSCM. Patients without 
appendix histopatology result and previous chemotherapy 
were excluded in this study. Consecutive method and 
random sampling were used in this study.
Results: A total of 80 subjects were included in this study. 
Subjects have average age of 48 years old. Out of all 
samples, 43 samples (53.8%) were defi ned as stage I patient, 
7 subjects (8.8%) as stage II, 30 subjects (37.5%) as stage 
III, and none as stage IV. Appendectomy were done and 
eight subjects (10%) experienced metastasis to appendix. A 
total of 19 subjects (23.8%) had chronic appendicitis and 53 
subjects (66.3%) did not have metastasis to the appendix. 
Among eight subjects having appendix involvement, 4 had 
mucinous histology, 2 serous, and 2 endometrioid. Six out 
of eight were diagnosed at clinical stage III and two were 
diagnosed at stage I. 
Conclusions: The prevalence of appendix metastases 
from primary surgery in ovarian epithelial cancer at RSCM 
was 10%. Based on this research, appendectomy can be 
considered on ovarian cancer surgery.
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Abstrak
Tujuan: Mengetahui prevalensi metastasis kanker epitelial 
ovarium ke apendiks pada pembedahan primer kanker 
epitelial ovarium di Rumah Sakit Umum Pusat Nasional Dr. 
Cipto Mangunkusumo (RSCM), Indonesia.
Metode: Penelitian ini merupakan studi potong lintang 
menggunakan data rekam medis pasien kanker ovarium 
epitelial yang menjalani pembedahan primer dan 
apendiktomi pada bulan Juli hingga Desember 2019 di 
RSCM Pasien tanpa histopatologi apendiks atau pernah 
dilakukan kemoterapi sebelumnya dieksklusi dari penelitian. 
Digunakan metode pengambilan sampel secara acak.
Hasil: Didapatkan 80 subjek penelitian yang diikutsertakan 
dalam penelitian. Dari 80 subjek penelitian, didapatkan 
rerata usia 48 tahun. Sebanyak 43 subjek (53,8%) didiagnosis 
dengan stadium I, 7 subjek (8,8%) sebagai stadium II, 30 
subjek (37,5%) stadium III. Dari 80 subjek yang menjalani 
apendiktomi, didapatkan 8 subjek (10%) anak sebar ke 
apendiks, 19 subjek (23,8 %)  apendisitis kronis, 53 subjek 
(66,3%) tidak terdapat anak sebar. Dari 8 subjek yang 
terdapat anak sebar ke apendiks dengan temuan histologi 4 
musinosum, 2 serosum, 2 endometroid. Sebanyak enam dari 
delapan subjek terdiagnosis pada stadium klinis stadium III 
dan dua lainnya pada stadium klinis satu.
Kesimpulan: Prevalensi metastasis apendiks pada operasi 
primer kanker ovarium epitelial di RSCM adalah sebesar 
10%. Berdasarkan hasil penelitian ini, apendektomi dapat 
dipertimbangkan dilakukan pada pembedahan baik stadium 
awal maupun stadium lanjut.
Kata kunci: apendiks , kanker ovarium, metastatis.
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INTRODUCTION
Ovarian cancer is one of the leading causes of 
morbidity and mortality of women in the world. 
It is the 7th most prevalent cancer in women and 
the 9th most prevalent of all cancer.1 Incidence 
of ovarian cancer is predicted to be 3.4% per 
year with 4.3% mortality rate.1 Over 90% of all 
malignant ovarian cancer is epithelial ovarian 
cancer. Epithelial ovarian cancer consists of various 
subtypes, such as serous, endometrioid, clear 
cell, mucinous, transitional cell, undifferentiated, 
and not classifi ed. Federation of Gynecology and 
Obstetrics (FIGO) in its guideline recommends 
surgical staging on ovarian cancer through 
fi nding during exploration.2 Optimally performed 
surgical staging is the key to treatment after 
surgery which supports accurate prognosis, better 
chemotherapy outcome, and higher survival rate 
by removing all tumour and its metastasis.
Appendix is an intraperitoneal organ prone to 
be a site of metastasis of epithelial ovarian cancer 
due to its anatomical site near paracloica space 
where ascites could build-up, especially in right 
ovarian cancer.3 Appendectomy is routinely done 
in patients with epithelial ovarian cancer subtype 
mucinous in order to exclude appendix carcinoma. 
There were some controversies regarding the 
decision of routine appendectomy in other 
subtypes of cancer, although previous study has 
shown that appendix pathologic examination 
would promote better staging and optimal 
cytoreduction.4  There was no previous research 
on metastasis to the appendix on epithelial 
ovarian cancer in our institution. Therefore, this 
study aims to determine the prevalence and 
characteristic of appendical metastasis of ovarian 
cancer undergoing primary surgery.
METHODS
A descriptive research with cross-sectional 
method with was done in National General 
Hospital Dr. Cipto Mangunkusumo Jakarta on 
July to December 2019. The study population 
were all ovarian cancer patients undergoing 
primary surgery with concurrent appendectomy. 
Patients without appendix histopathology and 
previous chemotherapy were excluded from 
this study. Total sampling method was done in 
regards to small prevalence in the population. 
Patients were then divided into metastasis and 
non-metastasis group. Baseline characteristics 
were analyzed and compared. Ethical clearance 
was issued from the ethical committee of Faculty 
of Medicine, Universitas Indonesia with letter 
number KET-636/UN2.F1/ETIK/PPM.00.02/2019.
RESULTS
During the course of the study, there were 
80 ovarian cancer patients undergoing primary 
surgery with appendectomy with the average 
age of 48.6 years. The proportion of metastasis 
to the appendix was 10% (8 subjects). Among 53 
(66.3%) patients who did not have metastasis to 
the appendix, 19 (23.8%) patients were found to 
have chronic appendicitis. Baseline characteristics 
of subjects can be found in Table 1. 
Subjects of this study were then categorized 
into two groups, namely positive metastasis to 
the appendix group {metastatis (+) group} and 
negative metastasis to the appendix group 
{metastatis (-) group}. Characteristics of subjects 
in each group can be found in Table 2.
Table 1. Baseline Characteristics of Subjects
Table 2. Characteristics of Subjects
Variables
Variables Study Groups
Metastasis (+) Metastasis (-)
N = 80
Age
Clinical Stage
I
II
III
IV
Subtype
Brenner
Mucinous
Serous
Endometrioid
Clear Cell 
Mixed
Metastasis to the Appendix
Positive
Negative
Age (years)
< 50 
> 50 
Clinical Stage
I
II
III
IV
3 (3.75)
5 (6.25)
2 (2.5)
0
6 (7.5)
0
40 (50)
32 (40)
41 (51.3)
7 (8.8)
24 (30)
0
48.6 (25 – 72)
43 (53.8
7 (8.8)
30 (37.5)
0 (0.0)
1 (1.3)
22 (27.5)
12 (15)
17 (21.3)
26 (32.5)
2 (2.5)
8 (10.0)
72 (90.0)
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Among 8 patients having metastasis to the 
appendix, some subjects were having more 
than one subtype of cell. Subtypes of cancer cell 
having metastasis to the appendix can be found 
in table 3.
DISCUSSION
In this study, it was found that the average age 
of subjects in this study was 48.6 years, lower than 
the average age of various studies showing that 
ovarian cancer patients having primary surgery 
would have an average age of 50 to 70 years old 
due to the lack of symptoms and compliance of 
older patients, probably delaying the treatment 
necessary.5,6 It was also found that the most 
prevalent subtypes in ovarian cancer in this study 
was clear cell subtype with proportion of 32.5%, 
followed by mucinous (27.5%), endometrioid 
(21,3%), serous (15%), and mixed type (1.3%). Cell 
subtypes is one of prognostic factors in epithelial 
ovarian cancer, with clear cell subtypes having 
worse progrnosis due to lower chemotherapy 
response.7 In earlier stage, clear cell subtype 
would have similar prognosis and even higher 
survival rate than serous type. However, it was 
not until advanced stage that clear cell subtype 
would give worse outcome to the patient.7
Epithelial ovarian cancer is mainly divided 
into fi ve subtypes according to its prevalence, 
namely high-grade serous carcinoma (HGSC), 
endometrioid carcinoma (EC), clear cell carcinoma 
(CCC), mucinous carcinoma (MC), and low-grade 
serous carcinoma (LGSC). Usually, HGSC would 
be diagnosed much later than other subtypes, in 
accordance to the fi nding  this study and previous 
studies.8,9 In this study, 50% of serous subtype 
were founded in advanced tumour stage, much 
higher than mucinous (31%), clear cell (37,5%), 
endometrioid (3.5%), and Brenner (0%).
Ovarian cancer spreads primarily in the 
abdominal and pelvic cavity. Although patients 
with early clinical stages usually do not have 
involvement with the appendix, evaluation of 
the appendix is needed during surgery because 
the involvement of the appendix will make 
cancer grading increase and require adjuvant 
treatment.4,9,10 Appendectomy should also 
be done in ovarian cancer patients due to its 
anatomical site, where ascites could build-up 
especially in right ovarian cancer and further 
increase the rate of metastasis.10
It was discovered that 10 per cent of the 
subjects of this study experienced involvement 
from the appendix. This percentage is still lower 
than other studies which stated that appendix 
involvement was 15% or even 29%.4,1 Ovarian 
epithelial cancer has a very poor prognosis at 
an advanced stage regardless of the subtype of 
cancer. In our study, the spread to the appendix 
was more severe at stage 3-4 (advanced stage) 
with a proportion of 20% compared to stage 1-2 
(early stage) with a percentage of 4 %. Higher 
percentage of metastasis in this study is related 
to higher stadium at the time of diagnosis.
Limitation of this study is the method used 
which is retrospective cohort to determine 
the prevalence of appendical metastasis in 
ovarian cancer. Further studies should be done 
prospectively to have higher degree of causality.
CONCLUSIONS
The prevalence of metastasis to the appendix in 
ovarian cancer patients having primary surgery 
and concurrent appendectomy in this study is 
10%. Ovarian cancers with appendix metastasis 
were made of various subtypes and clinical 
stages.
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Table 3. Subtype Distribution of Metastasis Ovarium Cancer 
to Appendix Metastasis
Subtype of
Histopathology Stage I Stage II Stage III
Mucinous
Serous
Endometrioid
2
0
0
0
0
0
2
2
2
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